Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,28 AUD | +1,82 % | +12,00 % | +47,37 % |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Howie McKibbon
CEO | Chief Executive Officer | - | 01/05/19 |
Vincent Ippolito
CHM | Chairman | 65 | 20/05/19 |
Chief Tech/Sci/R&D Officer | 68 | 01/03/21 | |
Henry Bosch
BRD | Director/Board Member | - | 01/07/16 |
Jack Hoblitzell
PRN | Corporate Officer/Principal | - | 24/09/21 |
Anthony Robinson
PRN | Corporate Officer/Principal | - | 01/03/21 |
Susan Park
SEC | Corporate Secretary | 49 | 17/04/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Stewart Washer
BRD | Director/Board Member | 54 | 21/02/19 |
Henry Bosch
BRD | Director/Board Member | - | 01/07/16 |
Vincent Ippolito
CHM | Chairman | 65 | 20/05/19 |
Matthew Callahan
FOU | Founder | 51 | 01/07/16 |
Daniel Sharp
BRD | Director/Board Member | - | 22/03/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 1 547 144 642 | 1 319 431 449 ( 85,28 %) | 0 | 85,28 % |
Información de la empresa
Botanix Pharmaceuticals Ltd.
661 Newcastle Street Unit D2
6007, Leederville
+
http://www.botanixpharma.comSector
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+47,37 % | 286 M | |
+7,22 % | 72,81 mil M | |
+12,72 % | 9126,35 M | |
-11,75 % | 5134,85 M | |
+59,61 % | 4992,02 M | |
+2,62 % | 3897,61 M | |
-17,54 % | 2481,2 M | |
+21,35 % | 2423,49 M | |
-27,82 % | 2318,04 M | |
+25,13 % | 2168 M |
- Bolsa de valores
- Acciones
- Acción BOT
- Empresa Botanix Pharmaceuticals Limited